This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Indeterminate sex and pseudohermaphroditism
Q17_INDET_SEX_PSEUDOHE
pseudohermaphroditism: A condition consisting of possessing the internal reproductive organs of one sex while exhibiting some of the secondary sex characteristics of the opposite sex.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
35 |
4. Check minimum number of eventsNone |
35 |
5. Include endpointsNone |
35 |
6. Filter based on genotype QC (FinnGen only) |
35 |
Control definitions (FinnGen only)
- Control exclude
- Q17_CONGEN_MALFO_GENITAL_ORGANS
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Q5
- Name in latin
- Pseudohermaphroditismus
Similar endpoints
↥List of similar endpoints to
Indeterminate sex and pseudohermaphroditism
based on the number of shared cases.
Similar with more cases:
- Congenital malformations of genital organs
- Congenital malformations, deformations and chromosomal abnormalities
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 331 | 197 | 133 |
| Only index persons | 269 | 168 | 101 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.00 | 0.01 | 0.00 |
| Only index persons | 0.01 | 0.01 | 0.00 |
| Median age at first event (years) | |||
| Whole population | 27.67 | 40.18 | 8.92 |
| Only index persons | 40.77 | 46.11 | 31.87 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 35 | 24 | 11 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.00 |
| Median age at first event (years) | 54.81 | 53.61 | 57.42 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
No data
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3000492) Spirometry study
7
16
5.18
2.62
1.3
1.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
9
30
3.67
2.35
1.1
1.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
5
9
6.26
2.29
1.2
1.6
u/ml
32.3
161.5
—
5
9
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
7
19
4.33
2.28
2.9
2.6
pmol/l
4.4
4.5
—
7
14
(40768797) Stomach Pathology biopsy report
9
36
3.01
1.91
1.2
1.2
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
5
12
4.66
1.89
8.6
1.5
nmol/l
7.6
14.0
—
5
12
(21494755) Public health laboratory ask at order entry panel
5
17
3.25
1.41
1.6
1.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
18
119
2.06
1.21
3.1
2.4
ug/l
71.9
97.3
0.82
18
101
(3042936) Bacteria identified in Isolate by Culture
7
36
2.17
1.04
2.1
2.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
7
36
2.17
1.04
8.9
7.8
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
19
242
0.53
0.96
13.9
18.8
%
13.7
14.1
0.63
19
237
(3032080) INR in Blood by Coagulation assay
17
121
1.79
0.84
6.9
6.8
inr
1.6
1.1
—
6
41
(3030981) Hyaline casts [#/volume] in Urine by Automated count
0
26
0.00
0.82
0.0
3.2
—
0.2
—
0
26
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
7
38
2.05
0.79
6.0
5.2
%
35.0
35.0
—
7
21
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
16
114
1.74
0.78
5.2
4.3
ng/l
78.3
58.2
0.11
11
86
(42870588) Differential panel, method unspecified - Blood
13
87
1.79
0.77
2.2
4.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
6
100
0.52
0.77
1.3
3.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
11
71
1.80
0.73
2.4
2.1
mg/l
2.8
3.3
0.42
11
58
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
6
99
0.53
0.64
1.5
2.8
u/l
21.5
27.1
—
6
92
(3015736) pH of Urine
15
111
1.61
0.60
3.2
4.2
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
9
120
0.66
0.45
3.0
3.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
13
99
1.50
0.44
2.2
2.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
15
118
1.47
0.43
5.1
4.6
—
—
—
0
0
(3019225) pH of Specimen
5
33
1.60
0.43
6.0
3.5
—
—
—
0
0
(3035941) MCH [Entitic mass]
30
316
0.65
0.42
21.3
23.4
pg
30.3
30.2
0.06
30
310
(3024731) MCV [Entitic volume]
30
316
0.65
0.42
21.4
23.5
fl
91.2
91.1
0.03
30
310
(3007461) Platelets [#/volume] in Blood
30
316
0.65
0.42
21.4
23.5
e9/l
251.3
247.9
0.12
30
308
(3000963) Hemoglobin [Mass/volume] in Blood
30
316
0.65
0.42
21.5
24.4
g/l
133.1
133.1
0.00
30
310
(3010813) Leukocytes [#/volume] in Blood
30
316
0.65
0.42
21.5
23.6
e9/l
6.8
6.7
0.14
30
304
(3026361) Erythrocytes [#/volume] in Blood
30
316
0.65
0.42
21.4
23.5
e12/l
4.4
4.4
0.05
30
305
(3000330) Specific gravity of Urine by Test strip
0
15
0.00
0.42
0.0
4.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
0
18
0.00
0.41
0.0
1.4
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
15
125
1.35
0.29
2.2
2.0
pmol/l
107.1
94.7
—
7
51
(3041096) Erythrocytes [Presence] in Urine by Automated
11
87
1.39
0.29
3.8
3.9
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
9
73
1.31
0.29
2.1
2.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
6
79
0.71
0.28
2.0
9.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
27
247
1.41
0.25
11.7
16.1
%
41.0
39.5
0.92
16
176
(3026008) Bacteria identified in Urine by Culture
9
111
0.75
0.25
2.6
3.8
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
5
39
1.33
0.24
2.0
2.2
umol/l
14.9
11.8
—
5
33
(40761511) CBC panel - Blood by Automated count
29
302
0.77
0.22
15.5
13.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
0
11
0.00
0.22
0.0
1.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
0
11
0.00
0.22
0.0
1.0
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
0
10
0.00
0.22
0.0
1.3
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
0
10
0.00
0.22
0.0
1.5
—
1.3
—
0
10
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
0
10
0.00
0.22
0.0
1.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
0
12
0.00
0.21
0.0
5.7
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
29
299
0.82
0.21
17.6
19.2
mmol/l
140.1
139.7
0.48
29
286
(3023103) Potassium [Moles/volume] in Serum or Plasma
29
299
0.82
0.21
17.6
19.1
mmol/l
3.9
4.0
0.18
29
286
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
5
65
0.73
0.19
3.4
4.5
ng/l
1154.4
105.9
—
5
55
(3023368) Bacteria identified in Blood by Culture
7
88
0.74
0.17
4.0
4.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
15
168
0.81
0.16
2.7
2.6
—
—
—
0
0
(3013512) EKG study
8
97
0.77
0.16
7.1
4.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
16
145
1.19
0.12
4.9
4.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
5
45
1.13
0.10
1.8
1.2
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
30
304
0.91
0.10
16.2
18.9
umol/l
73.9
77.5
0.35
30
304
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
5
63
0.76
0.09
4.0
4.8
ug/l
1.6
1.8
—
5
54
(40760892) CBC W Ordered Manual Differential panel - Blood
6
72
0.80
0.08
3.2
7.5
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
6
69
0.84
0.08
2.7
4.0
%
103.3
87.8
—
6
69
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
28
270
1.18
0.08
12.2
16.5
ml/min/173m2
81.1
75.8
0.59
23
217
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
7
80
0.84
0.08
1.1
1.7
mmol/l
1.4
1.2
—
7
65
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
25
261
0.85
0.08
7.3
6.4
mmol/mol
39.1
40.5
0.35
25
240
(36304419) Bacteria [Presence] in Urine
8
88
0.88
0.08
2.3
3.2
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
13
138
0.91
0.03
3.7
3.9
g/l
36.1
35.1
0.31
13
129
(3031040) Bacteria [#/volume] in Urine by Automated count
21
203
1.09
0.02
5.3
5.7
—
431.6
—
0
8
(40768804) Tissue Pathology biopsy report
12
123
0.96
0.00
2.5
2.0
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
21
207
1.04
0.00
5.4
5.0
—
—
—
0
0
(44806118)
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
0
5
0.00
0.00
0.0
7.0
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
5
48
1.05
0.00
4.4
5.6
mmol/l
0.9
1.0
—
5
42
(3005988) Vibrio sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
0
5
0.00
0.00
0.0
3.8
—
91.1
—
0
5
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
0
5
0.00
0.00
0.0
1.0
—
1.1
—
0
5
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
12.1
—
0
5
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
9
97
0.90
0.00
2.6
2.5
u/l
44.1
53.0
—
9
90
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(44790048)
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
0
5
0.00
0.00
0.0
5.8
—
59.0
—
0
5
(44790047)
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(44790049)
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
8
0.00
0.00
0.0
4.5
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.9
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
0
7
0.00
0.00
0.0
5.7
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
0
7
0.00
0.00
0.0
4.6
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
3.0
—
104.4
—
0
8
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
0
9
0.00
0.00
0.0
3.1
—
6.2
—
0
9
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.6
—
0.2
—
0
9
(3024891) Influenza virus A+B Ag [Presence] in Specimen
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
2.7
—
0
7
(3011397) Hemoglobin [Presence] in Urine by Test strip
6
63
0.94
0.00
6.0
4.5
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
2.2
—
199.0
—
0
6
(3013290) Carbon dioxide [Partial pressure] in Blood
0
9
0.00
0.00
0.0
3.8
—
5.0
—
0
9
(3035285) Chloride [Moles/volume] in Venous blood
0
6
0.00
0.00
0.0
2.7
—
108.8
—
0
6
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
0
9
0.00
0.00
0.0
5.8
—
96.9
—
0
9
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(4034850)
0
7
0.00
0.00
0.0
7.9
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
6.3
—
0
6
(3013727) Leukocytes other/100 leukocytes in Blood
0
6
0.00
0.00
0.0
5.3
—
58.9
—
0
6
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
0
7
0.00
0.00
0.0
4.3
—
3.5
—
0
7
(3023419) Bacteria identified in Sputum by Culture
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
5
57
0.86
0.00
6.0
3.5
mmol/l
0.8
0.8
—
5
52
(3036489) Thrombin time
0
7
0.00
0.00
0.0
3.0
—
23.1
—
0
7
(3048929) Epstein Barr virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
0
9
0.00
0.00
0.0
3.1
—
1.5
—
0
9
(3003694) ABO and Rh group [Type] in Blood
7
78
0.87
0.00
2.7
1.3
—
—
—
0
0
(3044889) 12 lead EKG panel
19
190
1.00
0.00
3.7
3.8
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
5
57
0.86
0.00
1.2
1.6
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.8
—
11.5
—
0
8
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
0
9
0.00
0.00
0.0
3.8
—
9.5
—
0
9
(3003181) Sodium [Moles/volume] in Urine
0
7
0.00
0.00
0.0
1.4
—
86.9
—
0
7
(3052851) Hemolysis interference index of Serum or Plasma
0
9
0.00
0.00
0.0
2.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
0
7
0.00
0.00
0.0
3.1
—
1.8
—
0
7
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
0
6
0.00
0.00
0.0
2.7
—
3.9
—
0
6
Mortality – FinRegistry
↥Association
Association between endpoint Q17_INDET_SEX_PSEUDOHE and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have Q17_INDET_SEX_PSEUDOHE.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: Q17_INDET_SEX_PSEUDOHE – Indeterminate sex and pseudohermaphroditism
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data